Peter N Kellogg - Net Worth and Insider Trading

Peter N Kellogg Net Worth

The estimated net worth of Peter N Kellogg is at least $11 Million dollars as of 2024-06-02. Peter N Kellogg is the Exe V-P & CFO of Merck & Co Inc and owns about 53,999 shares of Merck & Co Inc (MRK) stock worth over $7 Million. Peter N Kellogg is also the EVP, Finance and CFO of Biogen Inc and owns about 18,966 shares of Biogen Inc (BIIB) stock worth over $4 Million. Details can be seen in Peter N Kellogg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter N Kellogg has not made any transactions after 2011-08-12 and currently still holds the listed stock(s).

Transaction Summary of Peter N Kellogg

To

Peter N Kellogg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter N Kellogg owns 5 companies in total, including Yield10 Bioscience Inc (YTEN) , Merck & Co Inc (MRK) , and Biogen Inc (BIIB) among others .

Click here to see the complete history of Peter N Kellogg’s form 4 insider trades.

Insider Ownership Summary of Peter N Kellogg

Ticker Comapny Transaction Date Type of Owner
YTEN Yield10 Bioscience Inc 2015-09-10 director
MRK Merck & Co Inc 2011-08-12 Exec. V.P. & C.F.O
BIIB Biogen Inc 2007-03-20 EVP & CFO
LIMIT LIMIT 2009-11-03 Exec. V.P. & C.F.O
LIMIT LIMIT 2023-03-07 director

Peter N Kellogg Latest Holdings Summary

Peter N Kellogg currently owns a total of 2 stocks. Among these stocks, Peter N Kellogg owns 53,999 shares of Merck & Co Inc (MRK) as of August 12, 2011, with a value of $7 Million and a weighting of 61.38%. Peter N Kellogg also owns 18,966 shares of Biogen Inc (BIIB) as of March 20, 2007, with a value of $4 Million and a weighting of 38.62%.

Latest Holdings of Peter N Kellogg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MRK Merck & Co Inc 2011-08-12 53,999 125.54 6,779,034
BIIB Biogen Inc 2007-03-20 18,966 224.93 4,266,022

Holding Weightings of Peter N Kellogg


Peter N Kellogg Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter N Kellogg has made a total of 0 transactions in Merck & Co Inc (MRK) over the past 5 years. The most-recent trade in Merck & Co Inc is the acquisition of 15,800 shares on August 12, 2011, which cost Peter N Kellogg around $502,440.

According to the SEC Form 4 filings, Peter N Kellogg has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 7,252 shares on March 20, 2007, which brought Peter N Kellogg around $322,569.

Insider Trading History of Peter N Kellogg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter N Kellogg Trading Performance

GuruFocus tracks the stock performance after each of Peter N Kellogg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter N Kellogg is 14.77%. GuruFocus also compares Peter N Kellogg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter N Kellogg within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter N Kellogg's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter N Kellogg

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.11 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.51 LIMIT LIMIT LIMIT LIMIT LIMIT

Peter N Kellogg Ownership Network

Ownership Network List of Peter N Kellogg

No Data

Ownership Network Relation of Peter N Kellogg

Insider Network Chart

Peter N Kellogg Owned Company Details

What does Yield10 Bioscience Inc do?

Who are the key executives at Yield10 Bioscience Inc?

Peter N Kellogg is the director of Yield10 Bioscience Inc. Other key executives at Yield10 Bioscience Inc include 10 percent owner Jack W Schuler , VP Planning and Comms Lynne H Brum , and VP Fin and CAO Charles B Haaser .

Yield10 Bioscience Inc (YTEN) Insider Trades Summary

Over the past 18 months, Peter N Kellogg made no insider transaction in Yield10 Bioscience Inc (YTEN). Other recent insider transactions involving Yield10 Bioscience Inc (YTEN) include a net purchase of 822,098 shares made by Jack W Schuler ,

In summary, during the past 3 months, insiders sold 0 shares of Yield10 Bioscience Inc (YTEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 46,103 shares of Yield10 Bioscience Inc (YTEN) were sold and 45,857 shares were bought by its insiders, resulting in a net sale of 246 shares.

Yield10 Bioscience Inc (YTEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Yield10 Bioscience Inc Insider Transactions

No Available Data

Peter N Kellogg Mailing Address

Above is the net worth, insider trading, and ownership report for Peter N Kellogg. You might contact Peter N Kellogg via mailing address: Merck & Co., Inc, One Merck Drive., P.o. Box 100, Whitehouse Station Nj 08889-0100.

Discussions on Peter N Kellogg

No discussions yet.